galactosamine has been researched along with Coronary Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Landmesser, U; Lüscher, TF | 1 |
| McCully, KS; Olszewski, AJ; Szostak, WB | 1 |
2 other study(ies) available for galactosamine and Coronary Disease
| Article | Year |
|---|---|
Advancing RNA-targeted therapy for personalised prevention of coronary disease: focus on ANGPLT3.
Topics: Angiopoietin-Like Protein 3; Angiopoietin-like Proteins; Coronary Disease; Diabetes Mellitus; Galactosamine; Humans; Hypertriglyceridemia; Lipoproteins; Pharmaceutical Preparations; RNA; RNA, Messenger; Triglycerides | 2020 |
Plasma glucosamine and galactosamine in ischemic heart disease.
Topics: Adult; Arteriosclerosis; Cholesterol; Chromatography, Ion Exchange; Coronary Disease; Galactosamine; Glucosamine; Glycoproteins; Glycosaminoglycans; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Reference Values | 1990 |